Part 1: Biochemical Signals
Think of the ways we communicate daily – speaking, texting, calling, emailing. Now, imagine the human body as a vast network where cells also “talk” constantly. Though cells don’t use words, their “language” of biochemical, mechanical, and electrical signals orchestrates essential tissue repair and regeneration processes. At Molecular Matrix, Inc., we believe that understanding how these important cellular conversations influence orthopedic tissue repair will lead development of better regenerative therapies.
Image Credit: sciencepics / Shutterstock
Biological Signals: The Healing Language of Molecules
Biological signals are molecular instructions that guide critical processes like inflammation, cell migration, and tissue reconstruction. In orthopedic repair, they play vital roles in activating bone and cartilage repair, modulating inflammation, and coordinating various cell types. The key biological signals in orthopedic healing can typically be grouped into three categories: biochemical, mechanical, or electrical. This blog post, the first in a three-part series, delves into biochemical signals and sets the stage for a deeper exploration of each signal group.
Growth Factors: The Master Controllers of Healing
Growth factors are a group of proteins that stimulate cell growth, proliferation, and differentiation. The following growth factors play a crucial role in bone repair:
Bone Morphogenetic Proteins (BMPs): Among the most powerful growth factors for bone healing, BMPs are crucial in signaling mesenchymal stem cells (MSC) to differentiate into osteoblasts. BMP-2, for example, is FDA-approved for complex fracture and spinal fusion surgeries, proving its critical role in clinical bone repair. (Dumic-Cule et al., 2018)
Transforming Growth Factor-Beta (TGF-β): Essential for both inflammation control and cartilage formation, TGF-β promotes chondrocyte formation and helps regenerate damaged cartilage, making it crucial in joint and cartilage repair. (Wu et al., 2023)
Vascular Endothelial Growth Factor (VEGF): By stimulating blood vessel formation (angiogenesis), VEGF enhances nutrient delivery to healing tissues, supporting sustained tissue repair. (Maruyama et al., 2020)
Fibroblast Growth Factor (FGF): FGFs, especially FGF-2, are involved in cell proliferation and angiogenesis. FGF2 is important in tendon-to-bone healing, and repair of bone, cartilage, and tendons. In addition to acting as a mitotic promoter, FGF2 accelerates revascularization of the injured area, upregulates osteogenic and chondrogenic gene expression, and recruits and guides the migration of MSC. (Zhang et al., 2020)
Wnt proteins: The Wnt signaling pathway regulates many aspects of osteoblast physiology including proliferation, differentiation, matrix formation and mineralization, and apoptosis. Wnt proteins also activate osteoclasts which help shape and remodel bone during the final stage of healing. (Bodine and Komm, 2006)
Cytokines: Conductors of Inflammation
Cytokines are small proteins that mediate inflammation, essential for tissue repair.
Interleukin-1 beta (IL-1β) and Tumor Necrosis Factor-Alpha (TNF-α): These cytokines initiate inflammation through macrophage activation to facilitate phagocytosis of microbes and damaged tissue. However, they require precise regulation – excessive inflammation driven by their release of pro-inflammatory mediators can impair healing and activate osteoclasts for bone resorption. (Fullerton and Gillroy, 2016; Loi et al., 2016)
Interleukin-6 (IL-6): This cytokine is produced by many cell types and binds to both membrane-bound and soluble LDL-related protein receptors. IL-6 induces and/or activates osteoclast differentiation while inhibiting osteoblast activity or differentiation. (Takeuchi et al., 2021)
Chemokines: Recruiting Cells to the Repair Site
Chemokines act as the “job site recruiters”, attracting stem cells and immune cells to injured tissues.
CCL2: This powerful chemokine attracts MSC to the injury site and promotes crosstalk with macrophages and endothelial cells. (Shinohara et al., 2023)
SDF-1 and CXCR4 axis: Ischemia induces expression of SDF-1 (stromal cell-derived factor-1) which binds to the CXCR4 receptor expressed on MSC. The SDF-1/CXCR4 signaling axis is crucial in recruiting MSCs to the ischemic injury site. Inhibition of SDF-1 or blocking of CXCR4 has been shown to prevent MSC recruitment and results in impaired bone healing. (Kitaori et al., 2009; Hermann et al., 2015)
Extracellular Matrix (ECM) Proteins: Key Team Members in the Healing Process
The ECM, a network of proteins and molecules surrounding cells, is more than just structural support; it dynamically influences cell behavior during bone repair by releasing biochemical cues that direct cells to grow, migrate and differentiate. (Lin et al., 2020) Look for more on this topic in future blog posts.
Fibronectin: Guides the chemotactic recruitment, migration and adhesion of MSC and endothelial cells by sequestering growth factors at the injury site. (Klavert and van der Eerden, 2021).
Proteoglycans (link to previous post on proteoglycans): Sequester growth factors and promote collagen fibrillogenesis and mineralization.
Glycoproteins: Regulate calcium release and bone remodeling.
Coordinating the Process: Timing and Balance
While each biochemical signal is crucial to bone repair, timing and balance are key to successful healing. For instance, growth factors like BMPs and TGF-β must appear in specific sequences to guide MSCs from initial recruitment through differentiation. Similarly, cytokines help control the immune response and inflammation but must taper off to prevent excessive tissue damage.
Disruption in any stage or imbalance in signaling can lead to complications, such as delayed union (where the bone heals slowly) or non-union (where the bone fails to heal). Conditions like diabetes, for instance, can disrupt normal signaling pathways, leading to compromised healing. For this reason, researchers are investigating ways to modulate these signals to enhance bone repair, especially in people with impaired healing abilities.
Future Directions: Enhancing Bone Repair
Understanding biochemical signals has led to new therapeutic strategies for bone repair. One example is the use of BMP-based bone grafts to promote healing in complex fractures. Other promising research involves gene therapy techniques aimed at activating specific signaling pathways to accelerate healing.
Conclusion
The body’s process of repairing bone is a remarkable orchestration of biochemical signals, each playing a specific role to ensure that bones heal correctly and regain strength. At Molecular Matrix, Inc., we are using our understanding of these biochemical signals to develop more effective treatments for fractures and bone injuries, helping more patients recover faster and completely. (Kim and Lee, 2023) These innovative therapies will change the landscape of regenerative medicine and help individuals with chronic conditions or severe injuries regain full mobility and quality of life. To learn more, visit www.molecularmatrix.com
References:
Bodine PV, Komm BS. Wnt signaling and osteoblastogenesis. Rev Endocr Metab Disord. 2006 Jun;7(1-2):33-9. doi: 10.1007/s11154-006-9002-4. PMID: 16960757.
Dolkart O, Kazum E, Rosenthal Y, Sher O, Morag G, Yakobson E, Chechik O, Maman E. Effects of focused continuous pulsed electromagnetic field therapy on early tendon-to-bone healing. Bone Joint Res. 2021 May;10(5):298-306. doi: 10.1302/2046-3758.105.BJR-2020-0253.R2. PMID: 33934605; PMCID: PMC8160030.
Dumic-Cule I, Peric M, Kucko L, Grgurevic L, Pecina M, Vukicevic S. Bone morphogenetic proteins in fracture repair. Int Orthop. 2018 Nov;42(11):2619-2626. doi: 10.1007/s00264-018-4153-y. Epub 2018 Sep 15. PMID: 30219967.
Fullerton, J., Gilroy, D. Resolution of inflammation: a new therapeutic frontier. Nat Rev Drug Discov 15, 551–567 (2016). https://doi.org/10.1038/nrd.2016.39
Herrmann M, Verrier S, Alini M. Strategies to Stimulate Mobilization and Homing of Endogenous Stem and Progenitor Cells for Bone Tissue Repair. Front Bioeng Biotechnol. 2015 Jun 2;3:79. doi: 10.3389/fbioe.2015.00079. PMID: 26082926; PMCID: PMC4451737.
Kim, K.D., Lee, C.C., 2023. Osteogenic Cells and Microenvironment of Early Bone Development and Clinical Implication, in: Jin Wang, J., Wang, G., Lv, X., Sun, Z., Sunil Mahapure, K. (Eds.), Frontiers in Spinal Neurosurgery. IntechOpen. https://doi.org/10.5772/intechopen.1002037
Kitaori, T., Ito, H., Schwarz, E.M., Tsutsumi, R., Yoshitomi, H., Oishi, S., Nakano, M., Fujii, N., Nagasawa, T. and Nakamura, T. (2009), Stromal cell–derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis & Rheumatism, 60: 813-823. https://doi.org/10.1002/art.24330
Klavert, J., & J., B. C. (2021). Fibronectin in Fracture Healing: Biological Mechanisms and Regenerative Avenues. Frontiers in Bioengineering and Biotechnology, 9, 663357. https://doi.org/10.3389/fbioe.2021.663357
Lin, X., Patil, S., Gao, Y., & Qian, A. (2020). The Bone Extracellular Matrix in Bone Formation and Regeneration. Frontiers in Pharmacology, 11, 521497. https://doi.org/10.3389/fphar.2020.00757
Maruyama M, Rhee C, Utsunomiya T, Zhang N, Ueno M, Yao Z, Goodman SB. Modulation of the Inflammatory Response and Bone Healing. Front Endocrinol (Lausanne). 2020 Jun 11;11:386. doi: 10.3389/fendo.2020.00386. PMID: 32655495; PMCID: PMC7325942.
Shinohara I, Tsubosaka M, Toya M, Lee ML, Kushioka J, Murayama M, Gao Q, Li X, Zhang N, Chow SK, Matsumoto T, Kuroda R, Goodman SB. C-C Motif Chemokine Ligand 2 Enhances Macrophage Chemotaxis, Osteogenesis, and Angiogenesis during the Inflammatory Phase of Bone Regeneration. Biomolecules. 2023 Nov 18;13(11):1665. doi: 10.3390/biom13111665. PMID: 38002347; PMCID: PMC10669364.
Takeuchi T, Yoshida H, Tanaka S. Role of interleukin-6 in bone destruction and bone repair in rheumatoid arthritis. Autoimmun Rev. 2021 Sep;20(9):102884. doi: 10.1016/j.autrev.2021.102884. Epub 2021 Jul 3. PMID: 34229044.
Wu M, Wu S, Chen W, Li YP. The roles and regulatory mechanisms of TGF-β and BMP signaling in bone and cartilage development, homeostasis and disease. Cell Res. 2024 Feb;34(2):101-123. doi: 10.1038/s41422-023-00918-9. Epub 2024 Jan 24. PMID: 38267638; PMCID: PMC10837209.
Zhang J, Liu Z, Li Y, You Q, Yang J, Jin Y, Zou G, Tang J, Ge Z, Liu Y. FGF2: a key regulator augmenting tendon-to-bone healing and cartilage repair. Regen Med. 2020 Sep;15(9):2129-2142. doi: 10.2217/rme-2019-0080. Epub 2020 Nov 17. PMID: 33201773.
Comments